Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Presepsin-guided anakinra for pneumonia-related infection
2022-002390-28Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Jul 2022
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) comparing Presepsin-guided anakinra + standard of care with Standard of care (control) (2 arms). Primary endpoint: Progression into organ dysfunction. Started Jul 2022; status: completed.
02
Drugs
anakinra
03
Conditions
community-acquired pneumonia (CAP)hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on 2022-002390-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002390-28.